Printer Friendly

ST. JUDE MEDICAL, INC. REPORTS THIRD QUARTER RESULTS

 ST. JUDE MEDICAL, INC. REPORTS THIRD QUARTER RESULTS
 ST. PAUL, Minn., Oct. 14 /PRNewswire/ -- St. Jude Medical, Inc.,


(NASDAQ-NMS: STJM) today reported record third quarter results.
 Net sales for the third quarter ended Sept. 30, 1992 totaled $58,281,000, a 17.5 percent increase over net sales of $49,618,000 for the same period of the prior fiscal year. For the first nine months of 1992, net sales of $175,344,000 increased 11.7 percent over net sales of $156,994,000 for the comparable 1991 period.
 Net income for the third quarter was $25,292,000, or $.53 per share, a 25.8 percent increase over net income of $20,108,000, or $.42 per share, for the same period a year ago. For the nine months ended September 30, 1992, net income increased 21.7 percent to $75,237,000, or $1.57 per share, over net income of $61,846,000, or $1.29 per share, for the comparable period last year.
 Lawrence A. Lehmkuhl, president and chief executive officer, said, "Our third quarter results were again at record levels and surpassed our targeted sales and earnings growth rates for 1992. Our mechanical heart valve business was strong on a worldwide scale in the quarter with market share gains being registered internationally. In addition, sales and earnings were favorably impacted in the quarter by a weaker U.S. dollar."
 Commenting on the balance of the year, Lehmkuhl stated, "Though we face increasing global competition and heightened health care cost containment pressures, we remain cautiously optimistic about our performance for the fourth quarter. We continue to benefit from our worldwide market share leadership and favorable delivered cost position."
 St. Jude Medical, Inc., a multinational manufacturer and marketer of the world's most preferred mechanical heart valve with approximately 425,000 implantations since 1977, serves physicians worldwide with the highest quality products for cardiovascular care.
 CONSOLIDATED INCOME STATEMENT
 (DATA IN THOUSANDS EXCEPT EPS AND DIVIDENDS)
 Three Months Ended
 September 30
 1992 1991
 Net Sales $58,281 $49,618
 Cost of Sales 14,237 14,605
 Gross Profit 44,044 35,013
 Operating Expenses
 Selling, General & Administrative 10,504 9,357
 Research & Development 2,973 2,025
 Total Operating Expenses 13,477 11,382
 Operating Profit 30,567 23,631
 Other Income 3,382 3,158
 Income Before Taxes 33,949 26,789
 Income Tax Provision 8,657 6,681
 Net Income $25,292 $20,108
 Earnings per common share $.53 $.42
 Dividends per common share $.10 $.00
 Primary shares outstanding 47,880 48,112
 Nine Months Ended
 September 30
 1992 1991
 Net Sales $175,344 $156,994
 Cost of Sales 44,331 46,608
 Gross Profit 131,013 110,386
 Operating Expenses
 Selling, General & Administrative 32,458 29,641
 Research & Development 7,911 5,952
 Total Operating Expenses 40,369 35,593
 Operating Profit 90,644 74,793
 Other Income 10,345 8,783
 Income Before Taxes 100,989 83,576
 Income Tax Provision 25,752 21,730
 Net Income $75,237 $61,846
 Earnings per common share $1.57 $1.29
 Dividends per common share $ .20 $ .00
 Primary shares outstanding 47,977 48,058
 -0- 10/14/92
 /CONTACT: Steve Wilson, V.P. Finance & CFO, St. Jude, 612-481-7542/
 (STJM) CO: St. Jude Medical, Inc. ST: Minnesota IN: MTC SU: ERN


KH -- MN020 -- 0034 10/14/92 16:03 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 14, 1992
Words:563
Previous Article:ST. JUDE MEDICAL, INC. REPORTS THIRD QUARTER RESULTS
Next Article:THE RITZ-CARLTON HOTEL COMPANY WINS COVETED MALCOLM BALDRIGE NATIONAL QUALITY AWARD; FIRST HOTEL COMPANY TO RECEIVE HONOR
Topics:


Related Articles
ST. JUDE MEDICAL DECLARES QUARTERLY CASH DIVIDEND
FOURTH QUARTER NET INCOME OF $25.6 MILLION REPORTED BY ST. JUDE MEDICAL, INC.
ST. JUDE MEDICAL, INC. REPORTS FIRST QUARTER NET SALES AND NET INCOME
ST. JUDE MEDICAL, INC. ANNOUNCES QUARTERLY CASH DIVIDEND
ST. JUDE MEDICAL, INC. REPORTS SECOND QUARTER FINANCIAL RESULTS
ST. JUDE MEDICAL, INC. REPORTS SECOND QUARTER FINANCIAL RESULTS
FDA APPROVES THREE MORE SIZES OF ST. JUDE MEDICAL MECHANICAL HEART VALVE HEMODYNAMIC PLUS (HP) SERIES
ST. JUDE MEDICAL, INC. REPORTS THIRD QUARTER RESULTS
ST. JUDE MEDICAL REPORTS PROFITS UP 24% FOR QUARTER AND YEAR
St. Jude Medical Receives FDA Approval for the St. Jude Medical Mechanical Heart Valve SJM Masters Series With Silzone Coating

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters